LIDOCAINE HYDROCHLO

The Defense Logistics Agency awarded a firm fixed price delivery order under contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of 2.000 pounds of LIDOCAINE HYDROCHLORIDE with NSN 6505015865691 at a total contract value of $34.78. The award was issued on July 20, 2026, under solicitation SPE2DP26F7792, and performance is fulfilled through a single delivery to Fort Bragg, North Carolina, with FOB destination terms placing transportation costs and risks on the contractor until receipt at the designated federal facility. Inspection and acceptance are to be conducted by government representatives at the delivery point, with compliance required to contract specifications only, though no explicit technical, military, or pharmaceutical standards are documented in the publicly available information. The contractor is designated as a small business and has affirmed this status, triggering ongoing reporting obligations under FAR 52.219-1. Invoicing must adhere to DFARS 252.232-7003 and be submitted via Wide Area WorkFlow, with payment processed by the Defense Finance and Accounting Service at the designated Columbus, Ohio, remittance address. The delivery order prohibits the use of parcel post and requires traceable shipping methods for accountability, while the quantity is fixed with zero variance permitted. No options, extensions, or special requirements regarding security, personnel, or organizational conflict of interest are included. Contract administration is managed by Lisa Quinn, the contracting officer, with Shairy M. Cartagena serving as the administrative point of contact. Despite the minimal monetary value, the structure indicates a simplified acquisition process, likely under the Lowest Price Technically Acceptable (LPTA) methodology, with no evidence of competitive evaluation beyond price and basic compliance.